Clinical Cancer Research Versailles No Abst AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peruzzi, B.
Right arrow Articles by Bottaro, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peruzzi, B.
Right arrow Articles by Bottaro, D. P.
Clinical Cancer Research Vol. 12, 3657-3660, June 15, 2006
© 2006 American Association for Cancer Research

Molecular Pathways

Targeting the c-Met Signaling Pathway in Cancer

Benedetta Peruzzi and Donald P. Bottaro

Authors' Affiliation: Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: Donald P. Bottaro, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Building 10, CRC 1, West Room 3961, 10 Center Drive MSC 1107, Bethesda, MD 20892-1107. Phone: 301-402-6499; Fax: 301-402-0922; E-mail: dbottaro{at}helix.nih.gov.

On binding to the cell surface receptor tyrosine kinase (TK) known as c-Met, hepatocyte growth factor (HGF) stimulates mitogenesis, motogenesis, and morphogenesis in a wide range of cellular targets including, epithelial and endothelial cells, hematopoietic cells, neurons, melanocytes, and hepatocytes. These pleiotropic actions are fundamentally important during development, homeostasis, and tissue regeneration. HGF signaling also contributes to oncogenesis and tumor progression in several human cancers and promotes aggressive cellular invasiveness that is strongly linked to tumor metastasis. Our present understanding of c-Met oncogenic signaling supports at least three avenues of pathway selective anticancer drug development: antagonism of ligand/receptor interaction, inhibition of TK catalytic activity, and blockade of intracellular receptor/effector interactions. Potent and selective preclinical drug candidates have been developed using all three strategies, and human clinical trials in two of the three areas are now under way.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
A. Coxon, K. Rex, S. Meyer, J. Sun, J. Sun, Q. Chen, R. Radinsky, R. Kendall, and T. L. Burgess
Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met-dependent tumors in animal models
Mol. Cancer Ther., May 1, 2009; 8(5): 1119 - 1125.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Vuononvirta, N. J. Sebire, B. Messahel, N. Perusinghe, J. S. Reis-Filho, K. Pritchard-Jones, G. M. Vujanic, and C. Jones
Expression of Hepatocyte Growth Factor and Its Receptor Met in Wilms' Tumors and Nephrogenic Rests Reflects Their Roles in Kidney Development
Clin. Cancer Res., April 15, 2009; 15(8): 2723 - 2730.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. Yan, X. Zhou, X. Chen, D.-N. Hu, X. D. Dong, J. Wang, F. Lu, L. Tu, and J. Qu
MicroRNA-34a Inhibits Uveal Melanoma Cell Proliferation and Migration through Downregulation of c-Met
Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1559 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
N. Smotrov, A. Mathur, I. Kariv, C. M. Moxham, and N. Bays
Development of a Cell-Based Assay for Measurement of c-Met Phosphorylation Using AlphaScreenTM Technology and High-Content Imaging Analysis
J Biomol Screen, April 1, 2009; 14(4): 404 - 411.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
T. Y. Seiwert, R. Jagadeeswaran, L. Faoro, V. Janamanchi, V. Nallasura, M. El Dinali, S. Yala, R. Kanteti, E. E.W. Cohen, M. W. Lingen, et al.
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
Cancer Res., April 1, 2009; 69(7): 3021 - 3031.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. P. Eder, G. F. Vande Woude, S. A. Boerner, and P. M. LoRusso
Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
Clin. Cancer Res., April 1, 2009; 15(7): 2207 - 2214.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Komai, M. Fujiwara, Y. Fujii, H. Mukai, J. Yonese, S. Kawakami, S. Yamamoto, T. Migita, Y. Ishikawa, M. Kurata, et al.
Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry
Clin. Cancer Res., February 15, 2009; 15(4): 1170 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
L. T. Nguyen, T. Uchida, K. Murakami, T. Fujioka, and M. Moriyama
Helicobacter pylori virulence and the diversity of gastric cancer in Asia
J. Med. Microbiol., December 1, 2008; 57(12): 1445 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
G. K.Y. Chan, B. A. Lutterbach, B.-S. Pan, I. Kariv, and A. A. Szewczak
High-Throughput Analysis of HGF-Stimulated Cell Scattering
J Biomol Screen, October 1, 2008; 13(9): 847 - 854.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. Tiran, A. Oren, C. Hermesh, G. Rotman, Z. Levine, H. Amitai, T. Handelsman, M. Beiman, A. Chen, D. Landesman-Milo, et al.
A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway
Clin. Cancer Res., July 15, 2008; 14(14): 4612 - 4621.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Jin, R. Yang, Z. Zheng, M. Romero, J. Ross, H. Bou-Reslan, R. A.D. Carano, I. Kasman, E. Mai, J. Young, et al.
MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
Cancer Res., June 1, 2008; 68(11): 4360 - 4368.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Marsh, S. Dickinson, G. W. Neill, J. F. Marshall, I. R. Hart, and G. J. Thomas
{alpha}v{beta}6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation
Cancer Res., May 1, 2008; 68(9): 3295 - 3303.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Bakalian, J.-C. Marshall, P. Logan, D. Faingold, S. Maloney, S. Di Cesare, C. Martins, B. F. Fernandes, and M. N. Burnier Jr.
Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma
Clin. Cancer Res., February 15, 2008; 14(4): 951 - 956.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. K. Mantripragada, G. Spurlock, L. Kluwe, N. Chuzhanova, R. E. Ferner, I. M. Frayling, J. P. Dumanski, A. Guha, V. Mautner, and M. Upadhyaya
High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
Clin. Cancer Res., February 15, 2008; 14(4): 1015 - 1024.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Sulpice, J. Plouet, M. Berge, D. Allanic, G. Tobelem, and T. Merkulova-Rainon
Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity
Blood, February 15, 2008; 111(4): 2036 - 2045.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
R. Salgia
c-Met Receptor Tyrosine Kinase as a Therapeutic Target in Cancer
ASCO Educational Book, January 1, 2008; 2008(1): 113 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Beroukhim, G. Getz, L. Nghiemphu, J. Barretina, T. Hsueh, D. Linhart, I. Vivanco, J. C. Lee, J. H. Huang, S. Alexander, et al.
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
PNAS, December 11, 2007; 104(50): 20007 - 20012.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
R. Zachow and M. Uzumcu
The hepatocyte growth factor system as a regulator of female and male gonadal function
J. Endocrinol., December 1, 2007; 195(3): 359 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Xing
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
Endocr. Rev., December 1, 2007; 28(7): 742 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Takami, P. Kaposi-Novak, K. Uchida, L. E. Gomez-Quiroz, E. A. Conner, V. M. Factor, and S. S. Thorgeirsson
Loss of Hepatocyte Growth Factor/c-Met Signaling Pathway Accelerates Early Stages of N-nitrosodiethylamine Induced Hepatocarcinogenesis
Cancer Res., October 15, 2007; 67(20): 9844 - 9851.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Arena, A. Pisacane, M. Mazzone, P. M. Comoglio, and A. Bardelli
Genetic targeting of the kinase activity of the Met receptor in cancer cells
PNAS, July 3, 2007; 104(27): 11412 - 11417.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.